Lammertink Marieke H A, Huisman Jelle F, Bernsen Marie L E, Niekel Ronald A M, van Westreenen Henderik L, de Vos Tot Nederveen Cappel Wouter H, Spanier Bernhard W M
Department of Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, The Netherlands.
Department of Gastroenterology and Hepatology, Isala Hospital, Zwolle, The Netherlands.
Scand J Gastroenterol. 2021 Nov;56(11):1337-1342. doi: 10.1080/00365521.2021.1966091. Epub 2021 Sep 10.
In the Dutch National colorectal cancer (CRC) screening program, patients with a positive faecal immunochemical test (FIT) are referred for a colonoscopy. In a small proportion, because of contraindications, a computed tomographic colonography (CTC) is performed to rule out advanced neoplasia. The aim of our study is to evaluate the intra- and extra-colonic yield of CTC and its clinical implications.
In this retrospective cohort study, all FIT positive patients who underwent primary (instead of colonoscopy) or secondary CTC (after incomplete colonoscopy) between January 2014 and January 2018 were included. Relevant intra-colonic lesions on CTC were defined as lesions suspected for CRC or >10 mm. Relevant extra-colonic findings were defined as E3 and E4 using the E-RADS classification.
Of the 268 included patients, 66 (24.6%) were suspected to have CRC or 10 mm + lesion on CTC and 56 of them (84.8%) underwent an additional endoscopy. Another 20 patients with <10 mm lesions on CTC underwent additional endoscopy. Overall, 76/268 patients (28.4%) underwent confirmatory endoscopy of which 50 (18.7%) had histologic confirmed advanced neoplasia; 4.9% had CRC and 13.8% advanced adenoma. New relevant extra-colonic findings were detected in 13.8%.
In the Dutch National CRC screening program, a CTC was followed by an endoscopic procedure in more than a quarter of patients, resulting in a significant number of advanced neoplasia. Overall, one out of seven CTCs showed new relevant extra-colonic findings which may lead to further diagnostic/therapeutic work-up. Our results can be important for the informed consent procedure.
在荷兰国家结直肠癌(CRC)筛查项目中,粪便免疫化学检测(FIT)呈阳性的患者会被转诊进行结肠镜检查。在一小部分患者中,由于存在禁忌证,会进行计算机断层结肠成像(CTC)以排除进展期肿瘤。我们研究的目的是评估CTC的结肠内和结肠外病变检出率及其临床意义。
在这项回顾性队列研究中,纳入了2014年1月至2018年1月期间接受初次(而非结肠镜检查)或二次CTC(在结肠镜检查不完全之后)的所有FIT阳性患者。CTC上相关的结肠内病变定义为疑似CRC或大于10毫米的病变。使用E-RADS分类将相关的结肠外发现定义为E3和E4。
在纳入的268例患者中,66例(24.6%)在CTC上疑似患有CRC或有10毫米及以上病变,其中56例(84.8%)接受了额外的内镜检查。另外20例CTC上病变小于10毫米的患者也接受了额外的内镜检查。总体而言,268例患者中有76例(28.4%)接受了确诊性内镜检查,其中50例(18.7%)经组织学证实患有进展期肿瘤;4.9%患有CRC,13.8%患有进展性腺瘤。新的相关结肠外发现的检出率为13.8%。
在荷兰国家CRC筛查项目中,超过四分之一的患者在CTC检查后接受了内镜检查,发现了大量进展期肿瘤。总体而言,七分之一的CTC显示有新的相关结肠外发现,这可能导致进一步的诊断/治疗检查。我们的结果对于知情同意程序可能很重要。